therapy

David Quan, PharmD, pharmacy supervisor at UCSF Pharmaceutical Services, shows the many bottles of medication are commonly prescribed for kidney transplant patients at discharge. Photo by Susan Merrell A new …

In the summer of 2024, Emma Operacz, 21, was heading into her last semester at Eastern Michigan University, pursuing a psychology degree. She was in a sorority, had a big …

Docwire NewsCell Therapy Shows Potential for Reduced Immunosuppression After Kidney TransplantCell therapy MDR-101 allowed most human leukocyte antigen-matched kidney transplant recipients to taper off immunosuppression safely..1 hour ago news source

NatureReal-world eligibility, utilization, and barriers to CAR T-cell therapy in relapsed/refractory mantle cell lymphomaPrior to the advent of chimeric antigen receptor (CAR) T-cell therapy, patients with relapsed/refractory (R/R) mantle cell …

A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory decision …

Trainees in hematology, hematopoietic cell transplantation (HCT), and cellular therapy (CT) face complex patient care scenarios that require advanced skills in symptom management, communication, and shared decision-making. However, many report …

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech …

Abramson, Palomba JS, Gordon LI ML, Lunning MA, Wang M, Arnason J, et al. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre …

Competing interests HT received honoraria from AstraZeneca plc, Bristol Myers Squibb, Chugai Pharma, Janssen, Kyowa Kirin, Meiji Seika Pharma, Nippon Shinyaku, Mundipharma, Ono Pharmaceutical, SymBio pharmaceuticals, Takeda Pharmaceutical, Eisai, Fujimoto …

Muhammad Umair Mushtaq/LinkedIn Muhammad Umair Mushtaq, Associate Professor of Medicine (Hematology/Oncology and Transplantation/Cellular Therapy) at University of Kansas Medical Center, shared a post on LinkedIn: “The KU Bone Marrow Transplant …